We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIM
3826
AIM ImmunoTech
AIM
$7.17M
$22K ﹤0.01%
+125
New +$25K
ACNT icon
3827
Ascent Industries
ACNT
$134M
$21K ﹤0.01%
2,797
+2,508
+868% +$14.4K
AMPH icon
3828
Amphastar Pharmaceuticals
AMPH
$858M
$21K ﹤0.01%
1,037
-13,125
-93% -$255K
BB icon
3829
BlackBerry
BB
$5.27B
$21K ﹤0.01%
3,130
-17,071
-85% -$101K
CMRC
3830
Commerce.com Inc Series 1
CMRC
$184M
$21K ﹤0.01%
327
+119
+57% +$9.5K
CALC icon
3831
CalciMedica
CALC
$20.2M
$21K ﹤0.01%
+52
New +$15.3K
CGC
3832
Canopy Growth
CGC
$426M
$21K ﹤0.01%
87
-980
-92% -$223K
CKPT
3833
DELISTED
Checkpoint Therapeutics
CKPT
$21K ﹤0.01%
808
-3,831
-83% -$96.9K
CMCM
3834
Cheetah Mobile
CMCM
$94.7M
$21K ﹤0.01%
2,278
+2,245
+6,803% +$22.3K
FXI icon
3835
iShares China Large-Cap ETF
FXI
$4.16B
$21K ﹤0.01%
455
-1,651
-78% -$75.4K
HSII
3836
DELISTED
Heidrick & Struggles
HSII
$21K ﹤0.01%
706
-16,396
-96% -$411K
LFT
3837
Lument Finance Trust
LFT
$36.4M
$21K ﹤0.01%
+6,274
New +$18.4K
LYRA
3838
DELISTED
LYRA THERAPEUTICS INC
LYRA
$21K ﹤0.01%
38
-44
-54% -$24.8K
NEXA icon
3839
Nexa Resources
NEXA
$1.9B
$21K ﹤0.01%
+2,199
New +$16K
NFBK
3840
DELISTED
Northfield Bancorp
NFBK
$21K ﹤0.01%
1,708
-42,722
-96% -$474K
OXM icon
3841
Oxford Industries
OXM
$542M
$21K ﹤0.01%
315
-20,372
-98% -$1.05M
PAYS icon
3842
Paysign
PAYS
$735M
$21K ﹤0.01%
4,373
-30,311
-87% -$158K
PEBO icon
3843
Peoples Bancorp
PEBO
$1.49B
$21K ﹤0.01%
790
-18,987
-96% -$464K
PVBC
3844
DELISTED
Provident Bancorp
PVBC
$21K ﹤0.01%
1,726
-8,002
-82% -$78.9K
SENS icon
3845
Senseonics Holdings Inc
SENS
$409M
$21K ﹤0.01%
1,200
+195
+19% +$1.7K
SHG icon
3846
Shinhan Financial Group
SHG
$35.1B
$21K ﹤0.01%
693
-1,864
-73% -$53.2K
TCMD icon
3847
Tactile Systems Technology
TCMD
$537M
$21K ﹤0.01%
466
-17,523
-97% -$696K
TELA icon
3848
TELA Bio
TELA
$30.4M
$21K ﹤0.01%
1,380
-3,830
-74% -$62.2K
XENE icon
3849
Xenon Pharmaceuticals
XENE
$6.21B
$21K ﹤0.01%
1,348
+636
+89% +$7.44K
FFNW
3850
DELISTED
First Financial Northwest, Inc
FFNW
$21K ﹤0.01%
1,862
-1,325
-42% -$13.9K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.